Immediate Impact
1 by Nobel laureates 64 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Works of Melissa Plets being referenced
A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort
2021
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Melissa Plets | 488 | 423 | 501 | 56 | 1.1k | |
| Ali Amin | 737 | 236 | 419 | 73 | 1.3k | |
| Paulo Antônio Silvestre de Faria | 573 | 271 | 317 | 56 | 1.3k | |
| Kwai‐Fong Ng | 341 | 276 | 309 | 56 | 908 | |
| Mark D. Hafermann | 563 | 203 | 771 | 32 | 1.4k | |
| Noriomi Miyao | 435 | 292 | 754 | 42 | 1.3k | |
| H. Mildenberger | 257 | 313 | 532 | 48 | 1.2k | |
| Alessandra Felici | 351 | 475 | 163 | 49 | 1.1k | |
| S. Huan | 329 | 428 | 375 | 36 | 993 | |
| Ryu Kanzaki | 532 | 344 | 324 | 93 | 1.1k | |
| Stephen B. Riggs | 972 | 319 | 401 | 48 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...